Filing Details
- Accession Number:
- 0001209191-14-062658
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2014-10-09 16:43:06
- Reporting Period:
- 2014-10-07
- Filing Date:
- 2014-10-09
- Accepted Time:
- 2014-10-09 16:43:06
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1496671 | Calithera Biosciences Inc. | CALA | Pharmaceutical Preparations (2834) | 272366329 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1439101 | Morgenthaler Venture Partners Ix Lp | 2710 Sand Hill Road, Suite 100 Menlo Park CA 94025 | No | No | Yes | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2014-10-07 | 1,811,915 | $10.00 | 1,811,915 | No | 4 | C | Direct | |
| Common Stock | Acquisiton | 2014-10-07 | 350,000 | $10.00 | 2,161,915 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | C | Direct | |
| No | 4 | P | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | SERIES A PREFERRED STOCK | Acquisiton | 2014-10-07 | 10,999 | $0.00 | 10,999 | $0.00 |
| Common Stock | SERIES B PREFERRED STOCK | Acquisiton | 2014-10-07 | 419,181 | $0.00 | 419,181 | $0.00 |
| Common Stock | SERIES C PREFERRED STOCK | Acquisiton | 2014-10-07 | 747,540 | $0.00 | 747,540 | $0.00 |
| Common Stock | SERIES D PREFERRED STOCK | Acquisiton | 2014-10-07 | 634,195 | $0.00 | 634,195 | $0.00 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | No | 4 | C | Direct | ||
| 0 | No | 4 | C | Direct | ||
| 0 | No | 4 | C | Direct | ||
| 0 | No | 4 | C | Direct |
Footnotes
- The Series A Preferred Stock, Series B Preferred Stock, Series C Preferred Stock and Series D Preferred Stock automatically converted into Common Stock on a one-for-one basis immediately upon consummation of Issuer's initial public offering of Common Stock and had no expiration date.
- The securities are held by Morgenthaler Venture Partners IX, L.P. (MVP IX). The managing partner of MVP IX is Morgenthaler Management Partners IX, LLC (MMP IX). The Member of MMP IX is Ralph E. Christoffersen. As such, the Member of MMP IX shares voting and investment power over the securities held by MMP IX. The Member of MMP IX disclaims beneficial ownership of the securities held by MMP IX except to the extent of his pecuniary interest therein.
Billionaire Hedge Funds
